Carbapenemase-producing Gram-negative bacteria: Current epidemics, antimicrobial susceptibility and treatment options

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Carbapenemases, with versatile hydrolytic capacity against β-lactams, are now an important cause of resistance of Gram-negative bacteria. The genes encoding for the acquired carbapenemases are associated with a high potential for dissemination. In addition, infections due to Gram-negative bacteria with acquired carbapenemase production would lead to high clinical mortality rates. Of the acquired carbapenemases, Klebsiella pneumoniae carbapenemase (Ambler class A), Verona integron-encoded metallo-β-lactamase (Ambler class B), New Delhi metallo-β-lactamase (Ambler class B) and many OXA enzymes (OXA-23-like, OXA-24-like, OXA-48-like, OXA-58-like, class D) are considered to be responsible for the worldwide resistance epidemics. As compared with monotherapy with colistin or tigecycline, combination therapy has been shown to effectively lower case-fatality rates. However, development of new antibiotics is crucial in the present pandrug-resistant era.

Original languageEnglish
Pages (from-to)407-425
Number of pages19
JournalFuture Microbiology
Volume10
Issue number3
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Gram-Negative Bacteria
Integrons
Colistin
Lactams
Mortality
Klebsiella pneumoniae
Asp(5)-oxytocin
carbapenemase
Anti-Bacterial Agents
Enzymes
Infection
Genes
Therapeutics

Keywords

  • Carbapenemase
  • Combination therapy
  • Dissemination
  • Gram-negative bacteria
  • Resistance

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

@article{fa04a4c4c1d042b09750ca9f14a4a438,
title = "Carbapenemase-producing Gram-negative bacteria: Current epidemics, antimicrobial susceptibility and treatment options",
abstract = "Carbapenemases, with versatile hydrolytic capacity against β-lactams, are now an important cause of resistance of Gram-negative bacteria. The genes encoding for the acquired carbapenemases are associated with a high potential for dissemination. In addition, infections due to Gram-negative bacteria with acquired carbapenemase production would lead to high clinical mortality rates. Of the acquired carbapenemases, Klebsiella pneumoniae carbapenemase (Ambler class A), Verona integron-encoded metallo-β-lactamase (Ambler class B), New Delhi metallo-β-lactamase (Ambler class B) and many OXA enzymes (OXA-23-like, OXA-24-like, OXA-48-like, OXA-58-like, class D) are considered to be responsible for the worldwide resistance epidemics. As compared with monotherapy with colistin or tigecycline, combination therapy has been shown to effectively lower case-fatality rates. However, development of new antibiotics is crucial in the present pandrug-resistant era.",
keywords = "Carbapenemase, Combination therapy, Dissemination, Gram-negative bacteria, Resistance",
author = "Jean, {Shio Shin} and Lee, {Wen Sen} and Carlos Lam and Hsu, {Chin Wang} and Chen, {Ray Jade} and Hsueh, {Po Ren}",
year = "2015",
month = "3",
day = "1",
doi = "10.2217/FMB.14.135",
language = "English",
volume = "10",
pages = "407--425",
journal = "Future Microbiology",
issn = "1746-0913",
publisher = "Future Medicine Ltd.",
number = "3",

}

TY - JOUR

T1 - Carbapenemase-producing Gram-negative bacteria

T2 - Current epidemics, antimicrobial susceptibility and treatment options

AU - Jean, Shio Shin

AU - Lee, Wen Sen

AU - Lam, Carlos

AU - Hsu, Chin Wang

AU - Chen, Ray Jade

AU - Hsueh, Po Ren

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Carbapenemases, with versatile hydrolytic capacity against β-lactams, are now an important cause of resistance of Gram-negative bacteria. The genes encoding for the acquired carbapenemases are associated with a high potential for dissemination. In addition, infections due to Gram-negative bacteria with acquired carbapenemase production would lead to high clinical mortality rates. Of the acquired carbapenemases, Klebsiella pneumoniae carbapenemase (Ambler class A), Verona integron-encoded metallo-β-lactamase (Ambler class B), New Delhi metallo-β-lactamase (Ambler class B) and many OXA enzymes (OXA-23-like, OXA-24-like, OXA-48-like, OXA-58-like, class D) are considered to be responsible for the worldwide resistance epidemics. As compared with monotherapy with colistin or tigecycline, combination therapy has been shown to effectively lower case-fatality rates. However, development of new antibiotics is crucial in the present pandrug-resistant era.

AB - Carbapenemases, with versatile hydrolytic capacity against β-lactams, are now an important cause of resistance of Gram-negative bacteria. The genes encoding for the acquired carbapenemases are associated with a high potential for dissemination. In addition, infections due to Gram-negative bacteria with acquired carbapenemase production would lead to high clinical mortality rates. Of the acquired carbapenemases, Klebsiella pneumoniae carbapenemase (Ambler class A), Verona integron-encoded metallo-β-lactamase (Ambler class B), New Delhi metallo-β-lactamase (Ambler class B) and many OXA enzymes (OXA-23-like, OXA-24-like, OXA-48-like, OXA-58-like, class D) are considered to be responsible for the worldwide resistance epidemics. As compared with monotherapy with colistin or tigecycline, combination therapy has been shown to effectively lower case-fatality rates. However, development of new antibiotics is crucial in the present pandrug-resistant era.

KW - Carbapenemase

KW - Combination therapy

KW - Dissemination

KW - Gram-negative bacteria

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=84926153992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926153992&partnerID=8YFLogxK

U2 - 10.2217/FMB.14.135

DO - 10.2217/FMB.14.135

M3 - Article

C2 - 25812463

AN - SCOPUS:84926153992

VL - 10

SP - 407

EP - 425

JO - Future Microbiology

JF - Future Microbiology

SN - 1746-0913

IS - 3

ER -